Little-known Boston Omaha is a quiet compounder, while Outset Medical's dialysis treatment could change millions of lives.
During a bear market, the smartest investors are the ones who know when to go on the offense and look for the next multibagger stocks. In this video, Motley Fool contributors Jason Hall and Jeff Santoro explain why they think Boston Omaha (BOC -0.52%) and Outset Medical (OM 3.85%) could turn a $1,000 investment into $10,000 over the next decade.
*Stock prices used were the afternoon prices of Dec. 13, 2022. The video was published on Dec. 27, 2022.
Jason Hall has positions in Boston Omaha and Outset Medical. Jeff Santoro has positions in Boston Omaha and Outset Medical. The Motley Fool has positions in and recommends Boston Omaha and Outset Medical. The Motley Fool has a disclosure policy. Jason Hall is an affiliate of The Motley Fool and may be compensated for promoting its services. If you choose to subscribe through his link, he will earn some extra money that supports his channel. His opinions remain his own and are unaffected by The Motley Fool.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
